Representative before the EPO

Employment test 51 - 200 employees
Company dna potter clarkson llp
operating since 1889
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

Stephen Phillip McNeeney has worked on the following 14 EPO patent applications which have been published in the last five years:

EP11822219

NEW PROCESS FOR PREPARING CYCLOLIGNANS

IPC classification:
C07D 493/04
Agent:
Stephen Phillip McNeeney, Potter Clarkson LLP
Status:
PATENT GRANTED
EP11713851

BIS AROMATIC COMPOUNDS FOR USE AS LTC4 SYNTHASE INHIBITORS

IPC classification:
A61K 31/44, A61P 11/00, A61P 29/00, C07D 213/74, C07D 405/10, C07D 409/10
Agent:
Stephen Phillip McNeeney, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11825532

POLYMERIC PRODUCT WITH INNER ANTI-MICROBIAL LAYER AND OUTER PROTECTIVE LAYER

IPC classification:
A61L 27/54, A61L 29/16, A61L 31/16, B32B 27/08, C08K 3/00, C08K 5/00
Agent:
Stephen Phillip McNeeney, Potter Clarkson LLP
Agent:
Björn Widén, Brann AB
Status:
GRANT OF PATENT INTENDED
EP12775283

NEW ABUSE-RESISTANT PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OPIOID DEPENDENCE

IPC classification:
A61K 9/00, A61K 9/14, A61K 9/20, A61K 31/485
Agent:
Stephen Phillip McNeeney, Potter Clarkson LLP
Status:
PATENT GRANTED
EP12703125

NOVEL FORMULATIONS FOR DERMAL, TRANSDERMAL AND MUCOSAL USE 1

IPC classification:
A61K 9/00, A61K 9/70, A61K 47/06, A61K 47/10, A61K 47/14
Agent:
Stephen Phillip McNeeney, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11831014

PICROPODOPHYLLIN MONOHYDRATE OR POLYMORPH A IN CANCER THERAPY

IPC classification:
A61K 31/365, A61P 3/10, A61P 13/12, A61P 17/06, A61P 19/02, A61P 25/28, A61P 27/02, A61P 35/00
Agent:
Stephen Phillip McNeeney, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11703723

Inhibitors of PI3 kinase

IPC classification:
A61K 31/4985, A61P 35/00, C07D 487/04
Applicant:
Centro Nacional de Investigaciones Oncológicas (CNIO)
Agent:
Francisco Javier Sáez Granero, Elzaburu SLP
Agent:
Multiple attorneys, Potter Clarkson LLP
Status:
PATENT GRANTED
EP11709452

TRIAZOLO [4, 5 - B]PYRIDIN DERIVATIVES

IPC classification:
A61K 31/4192, A61K 31/437, A61P 9/10, A61P 19/02, A61P 25/28, A61P 29/00, A61P 31/12, A61P 33/00, A61P 35/00, C07D 471/04
Applicant:
Centro Nacional de Investigaciones Oncológicas (CNIO)
Agent:
Multiple attorneys, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11729141

USE OF PI3K INIBITORS FOR THE TREATMENT OF OBESITY, STEATOSIS AND AGEING

IPC classification:
A61K 31/35, A61K 31/4985, A61K 31/5377, A61K 45/06, C07D 471/10, C07D 487/04
Applicant:
Centro Nacional de Investigaciones Oncológicas (CNIO)
Agent:
Francisco Javier Sáez Granero, Elzaburu SLP
Agent:
Stephen Phillip McNeeney, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP12703537

NOVEL ANTIFUNGAL COMPOSITION

IPC classification:
A61K 9/00, A61K 31/00, A61K 31/13, A61K 31/137, A61K 47/10, A61K 47/12, A61K 47/18
Agent:
Stephen Phillip McNeeney, Potter Clarkson LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14725742

A SOLID NANOPARTICLE WITH INORGANIC COATING

IPC classification:
A61K 9/50, A61K 9/51
Agent:
Stephen Phillip McNeeney, Potter Clarkson LLP
Agent:
Brann AB
Status:
GRANT OF PATENT INTENDED
EP11702677

NEW PROCESSES FOR PRODUCING BENZOPHENONE DERIVATIVES

IPC classification:
C07C 41/30, C07C 45/72
Agent:
Multiple attorneys, Potter Clarkson LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP10803613

TRICYCLIC COMPOUNDS FOR USE AS KINASE INHIBITORS

IPC classification:
A61K 31/5025, A61P 35/00, C07D 487/14, C07D 491/14
Applicant:
Centro Nacional de Investigaciones Oncológicas (CNIO)
Agent:
Garreth Andrew Duncan, D Young & Co LLP
Agent:
Multiple attorneys, Potter Clarkson LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11831013

PICROPODOPHYLLIN POLYMORPHS B OR C FOR USE IN CANCER THERAPY

IPC classification:
A61K 31/365, A61P 3/10, A61P 25/28, A61P 35/00, C07D 493/04
Agent:
Stephen Phillip McNeeney, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN

Please Sign in to use this feature